|
|
Volumn 362, Issue 19, 2010, Pages 1846-1848
|
|
Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CABERGOLINE;
DOPAMINE RECEPTOR;
GLYCOSYLATED HEMOGLOBIN;
HYDROCORTISONE;
KETOCONAZOLE;
PASIREOTIDE;
SOMATOMEDIN C;
SOMATOSTATIN RECEPTOR 1;
SOMATOSTATIN RECEPTOR 2;
SOMATOSTATIN RECEPTOR 3;
SOMATOSTATIN RECEPTOR 5;
DOPAMINE 2 RECEPTOR;
DOPAMINE RECEPTOR STIMULATING AGENT;
DRUG DERIVATIVE;
ERGOLINE DERIVATIVE;
SOMATOSTATIN;
SOMATOSTATIN RECEPTOR;
ADRENAL CORTEX ADENOMA;
BINDING AFFINITY;
BODY WEIGHT;
CLINICAL FEATURE;
CORTICOTROPIN RELEASE;
CUSHING DISEASE;
DIASTOLIC BLOOD PRESSURE;
GLUCOSE HOMEOSTASIS;
HUMAN;
HYPERADRENOCORTICISM;
LETTER;
LOW DRUG DOSE;
MONOTHERAPY;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN TARGETING;
REMISSION;
STEROIDOGENESIS;
SYSTOLIC BLOOD PRESSURE;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
URINARY EXCRETION;
ADULT;
CLINICAL TRIAL;
DRUG ANTAGONISM;
DRUG COMBINATION;
FEMALE;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
PROSPECTIVE STUDY;
URINE;
ADULT;
DOPAMINE AGONISTS;
DRUG THERAPY, COMBINATION;
ERGOLINES;
FEMALE;
HUMANS;
HYDROCORTISONE;
KETOCONAZOLE;
MALE;
MIDDLE AGED;
PITUITARY ACTH HYPERSECRETION;
PROSPECTIVE STUDIES;
RECEPTORS, DOPAMINE D2;
RECEPTORS, SOMATOSTATIN;
SOMATOSTATIN;
|
|
EID: 77952298716
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1000094 Document Type: Letter |
|
Times cited : (228)
|
|
References (5)
|
